Acumen Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABOS and other ETFs, options, and stocks.About ABOS
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L.
CEODaniel J. O'Connell
CEODaniel J. O'Connell
Employees61
Employees61
HeadquartersNewton, Massachusetts
HeadquartersNewton, Massachusetts
Founded1996
Founded1996
Employees61
Employees61
ABOS Key Statistics
Market cap127.81M
Market cap127.81M
Price-Earnings ratio-0.96
Price-Earnings ratio-0.96
Dividend yield—
Dividend yield—
Average volume186.72K
Average volume186.72K
High today$2.18
High today$2.18
Low today$2.09
Low today$2.09
Open price$2.17
Open price$2.17
Volume92.84K
Volume92.84K
52 Week high$2.46
52 Week high$2.46
52 Week low$0.8551
52 Week low$0.8551
Stock Snapshot
With a market cap of 127.81M, Acumen Pharmaceuticals(ABOS) trades at $2.09. The stock has a price-to-earnings ratio of -0.96.
On 2025-12-28, Acumen Pharmaceuticals(ABOS) stock moved within a range of $2.09 to $2.18. With shares now at $2.09, the stock is trading 0.0% above its intraday low and -3.9% below the session's peak.
Trading volume for Acumen Pharmaceuticals(ABOS) stock has reached 92.84K, versus its average volume of 186.72K.
The stock's 52-week range extends from a low of $0.86 to a high of $2.46.
The stock's 52-week range extends from a low of $0.86 to a high of $2.46.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ABOS. This list is generated using Robinhood data, and it’s not a recommendation.